newsfilter
← Latest News
GlobeNewswire·

Stemline Therapeutics Names Robert M. Francomano Chief Commercial Officer

NEW YORK, Dec. 06, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel...